Clinical Trial Update: Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants [Phase 1]

View source ↗

Summary

This Phase 1 safety study (NCT01107587) of GSK's liquid Rotavirus vaccine in healthy infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 1 | Status: COMPLETED